Clinical trials
Completed Observational trials in Cameroon
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Elizabeth Glaser Pediatric AIDS Foundation | 3 |
| ANRS, Emerging Infectious Diseases | 2 |
| Association of Future African Neurosurgeons, Yaounde, Cameroon | 2 |
| Christian Doll | 2 |
| London School of Hygiene and Tropical Medicine | 2 |
| Cameroon Baptist Convention Health | 1 |
| Chantal Biya International Reference Centre for Research on Prevention and Management of HIV/AIDS | 1 |
| Dissou AFFOLABI | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Institut Pasteur | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 3 |
| Malaria | 3 |
| Tuberculosis | 3 |
| COVID-19 | 2 |
| Diabetes Mellitus | 2 |
| Disease | 2 |
| Surgical Wound Infection | 2 |
| Anemia | 1 |
| Burkitt Lymphoma | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.